Form 4: Allovir Director Jeffrey S. Bornstein Acquires 35,000 Restricted Stock Units
SEC Form 4 Filing
Director Jeffrey S. Bornstein acquired 35,000 Restricted Stock Units (RSUs) in Allovir, Inc. on June 6, 2024, according to a recent SEC filing.
Summary
- On June 6, 2024, Jeffrey S. Bornstein, a director of Allovir, Inc. (ALVR), acquired 35,000 Restricted Stock Units (RSUs).
- The RSUs were issued under the company's 2020 Stock Option and Grant Plan.
- Each RSU represents the contingent right to receive one share of Allovir's common stock.
- The shares will vest on the earlier of June 6, 2025, or the next annual meeting of the Issuer's stockholders, contingent upon Bornstein's continued service on the Board of Directors.
- Following the transaction, Bornstein directly owns 110,197 shares of common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director generally indicates confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of RSUs by a director signals confidence in the company's future.
Future Outlook
The vesting of the RSUs is contingent upon continued service on the Board of Directors, aligning the director's interests with the company's long-term performance.
Industry Context
Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. RSU grants are a common form of executive compensation in the biotechnology industry.
Comparison to Industry Standards
- RSU grants are a typical component of compensation packages for directors and executives in biotech companies like Allovir.
- Comparing the size of this RSU grant to similar grants at companies like Gilead, Vertex, or BioNTech would provide context on its relative significance.
- The vesting schedule is standard, aligning with typical industry practices for incentivizing long-term commitment.
Stakeholder Impact
- The RSU grant aligns the director's interests with those of shareholders, incentivizing long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: Jeffrey S. Bornstein acquired 35,000 Restricted Stock Units. |
| 06/06/2025 | Vesting date for the RSUs, contingent on continued service, or earlier if the next annual meeting occurs before this date. |
| 06/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.